Kolinsky Wealth Management, LLC Bristol Myers Squibb CO Transaction History

Kolinsky Wealth Management, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	$57.89 - $64.73 $44,227 - $49,453	-764 Reduced 15.71%	4,098 $237,000
Q2 2023 Aug 14, 2023	SELL	$63.71 - $70.74 $40,392 - $44,849	-634 Reduced 11.54%	4,862 $310,000
Q1 2023 May 15, 2023	BUY	$65.71 - $74.53 $5,519 - $6,260	84 Added 1.55%	5,496 $381,000
Q4 2022 Feb 14, 2023	BUY	$68.48 - $81.09 $51,565 - $61,060	753 Added 16.16%	5,412 $389,000
Q3 2022 Nov 14, 2022	BUY	$0.13 - $76.84 $91 - $53,788	700 Added 17.68%	4,659 $331,000
Q2 2022 Aug 15, 2022	SELL	$72.62 - $79.98 $17,356 - $19,115	-239 Reduced 5.69%	3,959 $305,000
Q1 2022 May 12, 2022	SELL	$61.48 - $73.72 $13,402 - $16,070	-218 Reduced 4.94%	4,198 $307,000
Q4 2021 Jan 20, 2022	BUY	$53.63 - $62.52 $236,830 - $276,088	4,416 New	4,416 $275,000

2,533

1.47B

31.6M

35M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $124B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Kolinsky Wealth Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Kolinsky Wealth Management, LLC with notifications on news.